Loading…
Life-Saving Medicines Export Act of 2006
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 4,105 other S bills in the 109th — cohort avg 35d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2006 · year_end · Copyright/Patent/Trademark
HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, imporation, patent issues S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues S 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To Amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To amend title 35, United States Code, to conform certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 3818, Patent Reform Act of 2006 S 3175, Life-Saving Medicines Export Act of 2006, compulsory licensing S 3834, Online Pharmacy Consumer Protection Act of 2006, prescription drugs S 1903, Generic Prescription Drug Fairness Act of 2005, authorized generics and rebates
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $5,800,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
2006 · year_end · Copyright/Patent/Trademark
HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, imporation, patent issues S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues S 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To Amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To amend title 35, United States Code, to conform certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 3818, Patent Reform Act of 2006 S 3175, Life-Saving Medicines Export Act of 2006, compulsory licensing S 3834, Online Pharmacy Consumer Protection Act of 2006, prescription drugs S 1903, Generic Prescription Drug Fairness Act of 2005, authorized generics and rebates
Client expense: $7,720,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
2006 · year_end · Pharmacy
S. 3175, Life-Saving Medicines Export Act of 2006. H.R. 6257, Access to Life-Saving Medicine Act. S. 4016, Access to Life-Saving Medicine Act. Matters relating to the Best Pharmaceuticals for Children Act reauthorization and Pediatric Research Equity Act reauthorization. Matters relating to the Prescription Drug User Fee Act reauthorization. S. 3695, A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs. H.R. 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs. S. 3981, Citizen Petition Fairness and Accuracy Act of 2006. S. 2300, Lower PRICED Drugs Act. H.R. 6022, Lower PRICED Drugs Act. H.R. 5533, Biodefense and Pandemic Vaccine and Drug Development Act of 2006. S. 2564, Biodefense and Pandemic Vaccine and Drug Development Act of 2006, Sec. 5.
Client expense: $680,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2006 · year_end · Trade (domestic/foreign)
Work on the potential Peru Trade Promotion Agreement and the Colombia Trade Promotion Agreement in 2007 S. 3175 The Life Saving Medicines Export Act of 2006, All Sections
Client expense: $162,966 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office